CACI to acquire Advanced Programs Group

Bob Mitchell | | Health Imaging | Oncology Imaging
CACI International signed a definitive agreement to acquire Advanced Programs Group, an Oracle Platinum Partner and provider of Oracle e-Business services in the federal market. The acquisition expands CACI’s presence in business and government transformation.

Advanced Programs Group (APG) of Reston, Va., founded in 2004, services Oracle e-Business Suite (EBS) implementations, IT program management, enterprise architecture and security services. APG manages the lifecycle of Oracle implementations, including design, configuration, testing, deployment, maintenance and enhancement phases.

APG has contracts with several civilian and Department of Defense clients, including the National Institutes of Health (NIH) and the Department of the Interior’s (DOI) National Business Center (NBC), a shared service center that provides financial systems for government agencies.

APG has 110 employees. Its revenue for calendar year 2010 was $41.9 million. The acquisition is expected to be accretive to CACI’s earnings per share during its first 12 months.

Bob Mitchell

Related Content

High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery
MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.